1)  Imatinib
伊马替尼
1.
Efficacy and safety of Imatinib for Ph positive patients of chronic myeloid leukemia;
伊马替尼治疗Ph染色体阳性慢性粒细胞白血病的临床观察
2.
Establishment of an Imatinib Resistance Cell Line K562R and Its Resistant Principia;
体外诱导K562细胞伊马替尼耐药及其机理的初步探讨
3.
Imatinib mesylate combined with hematopiotic stem cell transplantation for chronic myloid leukemia;
伊马替尼联合造血干细胞移植治疗慢性粒细胞白血病
2)  Imatinib
Imatinib
1.
Research advances in the mechanisms of imatinib resistance in GIST;
GIST中imatinib耐药机制研究进展
2.
Effect of JNK and Bim in K562 Leukemia Cell Resistance to Imatinib, KR;
JNK及Bim在人红白血病耐Imatinib细胞系KR中的作用
3.
Objective To investigate whether imatinib in combination with meisoindigo can accelerate apoptosis of K562 cells.
目的研究甲异靛联合imatinib促进K562细胞凋亡的作用。
3)  Imatinib
甲磺酸伊马替尼
1.
Curative effect of imatinib in the treatment of unresectable/recurrent/metastatic gastrointestinal stromal tumor;
甲磺酸伊马替尼治疗手术后复发和/或转移的胃肠道间质瘤的疗效分析
2.
Clinical Efficacy of Imatinib Meylate in Treatment of Patients with Chronic Myeloid Leukemia in Advanced Phase;
甲磺酸伊马替尼治疗进展期慢性粒细胞白血病的临床疗效观察
4)  Imatinib
伊马替伲
5)  imatinib
格列卫
1.
Evidence-Based Treatment of a Patient with Chronic-Phase Chronic Myeloid Leukemia by Imatinib;
格列卫在1例慢性粒细胞白血病慢性期患者中的循证应用
2.
Objective To study the treatment and its possible mechanism of imatinib-induced severe fluid retention in chromic myeloid leukemia(CML).
目的探讨应用伊马替尼(格列卫)治疗慢性粒细胞白血病发生严重水潴留的处理及其可能的发生机制。
6)  imatinib
依曼替尼布
1.
A novel antineoplastic agents: imatinib;
新型抗肿瘤药物依曼替尼布
参考词条
补充资料：甲磺酸伊马替尼
分子量 589.7
分子式 C29H31N7O · CH4SO3 
   商品名为Gleevec,是由Novartis AG制药公司研制开发的。甲磺酸伊马替尼的化学名称为4-[(4-甲基-1-哌嗪)甲基]-N-[4-甲基-3-[[4-(3-吡啶)-2-嘧啶]氨基]苯基]-苯胺甲磺酸盐，是一种2-苯胺嘧啶的衍生物。白色至微黄色晶体粉末。溶于酸性缓冲溶液中，溶于二甲基亚砜、甲醇、乙醇，不溶于正辛醇、丙酮和乙腈。是一种抗癌药物。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。